A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Clinical trial NCT06411249 · RECRUITING

Trial details

NCT number: NCT06411249
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2024-06-06
Primary completion: 2027-05-31
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.